Bergenstal RM - Search Results

1

Efficacy of once-weekly tirzepatide versus once-daily insulin degludec on glycaemic control measured by continuous glucose monitoring in adults with type 2 diabetes (SURPASS-3 CGM): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial.

Battelino T, Bergenstal RM, Rodríguez A, Fernández Landó L, Bray R, Tong Z, Brown K. Battelino T, et al. Among authors: bergenstal rm. Lancet Diabetes Endocrinol. 2022 Jun;10(6):407-417. doi: 10.1016/S2213-8587(22)00077-8. Epub 2022 Apr 22. Lancet Diabetes Endocrinol. 2022. PMID: 35468321 Clinical Trial.

2

Intensified diabetes management: lessons from the diabetes control and complications trial.

Mazze RS, Bergenstal R, Ginsberg B. Mazze RS, et al. Int J Clin Pharmacol Ther. 1995 Jan;33(1):43-51. Int J Clin Pharmacol Ther. 1995. PMID: 7711992 Review.

3

Impact of modem-transferred blood glucose data on clinician work efficiency and patient glycemic control.

Bergenstal RM, Anderson RL, Bina DM, Johnson ML, Davidson JL, Solarz-Johnson B, Kendall DM. Bergenstal RM, et al. Diabetes Technol Ther. 2005 Apr;7(2):241-7. doi: 10.1089/dia.2005.7.241. Diabetes Technol Ther. 2005. PMID: 15857225 Clinical Trial.

4

Efficacy of inhaled insulin in patients with type 2 diabetes not controlled with diet and exercise: a 12-week, randomized, comparative trial.

DeFronzo RA, Bergenstal RM, Cefalu WT, Pullman J, Lerman S, Bode BW, Phillips LS; Exubera Phase III Study Group. DeFronzo RA, et al. Among authors: bergenstal rm. Diabetes Care. 2005 Aug;28(8):1922-8. doi: 10.2337/diacare.28.8.1922. Diabetes Care. 2005. PMID: 16043733 Clinical Trial.

5

Effects of exenatide versus insulin analogues on weight change in subjects with type 2 diabetes: a pooled post-hoc analysis.

Glass LC, Qu Y, Lenox S, Kim D, Gates JR, Brodows R, Trautmann M, Bergenstal RM. Glass LC, et al. Among authors: bergenstal rm. Curr Med Res Opin. 2008 Mar;24(3):639-44. doi: 10.1185/030079908X260862. Epub 2008 Jan 23. Curr Med Res Opin. 2008. PMID: 18218179 Clinical Trial.

6

Adjust to target in type 2 diabetes: comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine.

Bergenstal RM, Johnson M, Powers MA, Wynne A, Vlajnic A, Hollander P, Rendell M. Bergenstal RM, et al. Diabetes Care. 2008 Jul;31(7):1305-10. doi: 10.2337/dc07-2137. Epub 2008 Mar 25. Diabetes Care. 2008. PMID: 18364392 Free PMC article. Clinical Trial.

7

Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis.

Mazze RS, Strock E, Wesley D, Borgman S, Morgan B, Bergenstal R, Cuddihy R. Mazze RS, et al. Diabetes Technol Ther. 2008 Jun;10(3):149-59. doi: 10.1089/dia.2007.0293. Diabetes Technol Ther. 2008. PMID: 18473688

8

Effects of intensive glucose lowering in type 2 diabetes.

Action to Control Cardiovascular Risk in Diabetes Study Group; Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT. Action to Control Cardiovascular Risk in Diabetes Study Group, et al. N Engl J Med. 2008 Jun 12;358(24):2545-59. doi: 10.1056/NEJMoa0802743. Epub 2008 Jun 6. N Engl J Med. 2008. PMID: 18539917 Free PMC article. Clinical Trial.

9

Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study.

Drucker DJ, Buse JB, Taylor K, Kendall DM, Trautmann M, Zhuang D, Porter L; DURATION-1 Study Group. Drucker DJ, et al. Lancet. 2008 Oct 4;372(9645):1240-50. doi: 10.1016/S0140-6736(08)61206-4. Epub 2008 Sep 7. Lancet. 2008. PMID: 18782641 Clinical Trial.

10

Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea.

Bergenstal R, Lewin A, Bailey T, Chang D, Gylvin T, Roberts V; NovoLog Mix-vs.-Exenatide Study Group. Bergenstal R, et al. Curr Med Res Opin. 2009 Jan;25(1):65-75. doi: 10.1185/03007990802597951. Curr Med Res Opin. 2009. PMID: 19210140 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

345 results

Search Page